Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Eric Devroe

COO at Acrivon Therapeutics, Inc. (ACRV)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-10.7%
vs. S&P 500-12.1%
Beat the market0%
Paper profit on buys+$2K
Total bought / sold$17K / $1K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 20SEC ACRVAcrivon Therapeutics, Inc. Sell 604146,349 held (−0%) $2.01 $1K -5.0%
Jan 15SEC ACRVAcrivon Therapeutics, Inc. Buy 10,00075,308 held (+15%) $1.72 $17K +11.0%
  • Buy

    COO Eric Devroe bought $17K of ACRV at $1.72 — first open-market purchase in our records.